Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 4Venous Thrombosis 3Neoplasms 3Thromboembolism 2Pulmonary Embolism 2Ovarian Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Sarcoma 1Postoperative Complications 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 4ferric carboxymaltose 3Ropivacaine 3Neoadjuvant Therapy 3Exercise 3Ultrasonography 2Tranexamic Acid 2Surgical Procedures, Operative 2Standard of Care 2Sodium Chloride 2Sevoflurane 2Psychiatric Rehabilitation 2Propofol 2Proctectomy 2Preoperative Exercise 2Oxaliplatin 2Lymph Node Excision 2Immunonutrition Diet 2Hepatectomy 2Fluorouracil 2Fibrin Tissue Adhesive 2Ethanol 2Dexamethasone 2Counseling 2Colectomy 2Blood Specimen Collection 2Bevacizumab 2vapreotide 1streptococcal preparation 722 1methyl N-acetylsibirosaminide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × Fondaparinux × Clear all
NCT00539942 2017-03-27

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

University of Alabama at Birmingham

Phase 3 Terminated
7 enrolled 9 charts

Postoperative Complications, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡